Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Return on Assets (2017 - 2021)

Historic Return on Assets for ENDRA Life Sciences (NDRA) over the last 5 years, with Q3 2021 value amounting to 0.64%.

  • ENDRA Life Sciences' Return on Assets rose 28400.0% to 0.64% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.64%, marking a year-over-year increase of 28400.0%. This contributed to the annual value of 1.47% for FY2020, which is 3800.0% up from last year.
  • As of Q3 2021, ENDRA Life Sciences' Return on Assets stood at 0.64%, which was up 28400.0% from 0.61% recorded in Q2 2021.
  • ENDRA Life Sciences' Return on Assets' 5-year high stood at 0.49% during Q3 2017, with a 5-year trough of 6.06% in Q1 2017.
  • Over the past 5 years, ENDRA Life Sciences' median Return on Assets value was 2.3% (recorded in 2018), while the average stood at 2.23%.
  • Data for ENDRA Life Sciences' Return on Assets shows a peak YoY increase of 45400bps (in 2018) and a maximum YoY decrease of -40000bps (in 2018) over the last 5 years.
  • ENDRA Life Sciences' Return on Assets (Quarter) stood at 0.79% in 2017, then tumbled by -191bps to 2.3% in 2018, then decreased by -7bps to 2.47% in 2019, then skyrocketed by 33bps to 1.66% in 2020, then skyrocketed by 62bps to 0.64% in 2021.
  • Its Return on Assets was 0.64% in Q3 2021, compared to 0.61% in Q2 2021 and 0.77% in Q1 2021.